Advertisement

Biogerontology

, Volume 15, Issue 4, pp 317–328 | Cite as

Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study

  • Joanna Collerton
  • Hannah E. Gautrey
  • Sanne D. van Otterdijk
  • Karen Davies
  • Carmen Martin-Ruiz
  • Thomas von Zglinicki
  • Thomas B. L. Kirkwood
  • Carol Jagger
  • John C. Mathers
  • Gordon StrathdeeEmail author
Research Article

Abstract

Frailty is a major health problem in older people and, as the population ages, identification of its underlying biological mechanisms will be increasingly important. DNA methylation patterns within genomic DNA change during ageing and alterations in DNA methylation, particularly at gene promoter regions, can lead to altered gene expression. However the importance of altered DNA methylation in frailty is largely unknown. Using cross-sectional data from the Newcastle 85+ Study (all participants aged 85 years) frailty was operationalized by the Fried model. DNA methylation levels were assessed by highly quantitative pyrosequencing at the gene promoter associated CpG islands from a panel of five age-related methylation marker loci and at LINE-1 repetitive elements (as a surrogate for genome-wide methylation). While genome-wide methylation (as assessed at LINE-1 elements) showed no association with frailty status, there was a clear association between CpG island methylation and frailty. When compared to participants with CpG island methylation levels in the combined middle two (referent) quartiles, those in the lowest quartile had significantly decreased odds of frailty [odds ratio 0.47 (95 % CI 0.26–0.85); n = 321, p = 0.013]. Overall this study suggests a potential role for age-related changes in CpG island methylation in the development of frailty.

Keywords

Ageing Frailty DNA methylation CpG island Epigenetics 

Notes

Acknowledgments

Thanks are especially due to the 85 year olds of Newcastle and North Tyneside, and their families and carers, for the generous donation of their time and personal information to make the study possible. In addition we thank the: research nurses (Brenda Balderson, Sally Barker, Julie Burrows, June Edwards, Julie Ferguson, Gill Hedley, Joan Hughes, Judith Hunt, Julie Kimber and Victoria Raynor); biomarker technicians (Sam Jameson, Claire Kolenda, Craig Parker and Anna Tang); data manager (Pauline Potts); project secretary (Lucy Farfort); and the North of England Commissioning Support Unit (formerly NHS North of Tyne, working on behalf of Newcastle and North Tyneside Primary Care Trusts and Northumberland Care Trust) and local general practices. The Newcastle 85+ Study was funded by a combined grant from the UK Medical Research Council and the Biotechnology and Biological Sciences Research Council (G0500997), the Dunhill Medical Trust (R124/0509), and a grant from the Newcastle Healthcare Charity. The research was also supported by the National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. HG was funded by a PhD studentship from the Biotechnology and Biological Sciences Research Council and SvO was funded by a PhD studentship from the National Institute for Health Research Newcastle Biomedical Research Centre and a project grant from the Newcastle Healthcare Charity and Newcastle upon Tyne hospitals NHS Charity.

Supplementary material

10522_2014_9500_MOESM1_ESM.pdf (457 kb)
Supplementary material (PDF 457 kb)

References

  1. Avila-Funes JA, Helmer C, Amieva H, Barberger-Gateau P, Le Goff M, Ritchie K, Portet F, Carriere I, Tavernier B, Gutierrez-Robledo LM, Dartigues JF (2008) Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol Ser A Biol Sci Med Sci 63:1089–1096CrossRefGoogle Scholar
  2. Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol Ser A Biol Sci Med Sci 61:262–266CrossRefGoogle Scholar
  3. Bellizzi D, D’Aquila P, Montesanto A, Corsonello A, Mari V, Mazzei B, Lattanzio F, Passarino G (2012) Global DNA methylation in old subjects is correlated with frailty. Age 34:169–179PubMedCentralPubMedCrossRefGoogle Scholar
  4. Bird AP (1996) The relationship of DNA methylation to cancer. Cancer Surv 28:87–101PubMedGoogle Scholar
  5. Bird AP, Wolffe AP (1999) Methylation-induced repression—belts, braces, and chromatin. Cell 99:451–454PubMedCrossRefGoogle Scholar
  6. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstrom TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, Feinberg AP (2008) Intra-individual change over time in DNA methylation with familial clustering. J Am Med Assoc 299:2877–2883CrossRefGoogle Scholar
  7. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA (2009) The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 4:e6767PubMedCentralPubMedCrossRefGoogle Scholar
  8. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas P, Baccarelli A (2009) Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 130:234–239PubMedCentralPubMedCrossRefGoogle Scholar
  9. Bortz WM 2nd (2002) A conceptual framework of frailty: a review. J Gerontol Ser A Biol Sci Med Sci 57:M283–M288CrossRefGoogle Scholar
  10. Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men Research, G (2007) Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 55:1216–1223PubMedCrossRefGoogle Scholar
  11. Cigolle CT, Ofstedal MB, Tian Z, Blaum CS (2009) Comparing models of frailty: the Health and Retirement Study. J Am Geriatr Soc 57:830–839PubMedCrossRefGoogle Scholar
  12. Collerton J, Barrass K, Bond J, Eccles M, Jagger C, James O, Martin-Ruiz C, Robinson L, von Zglinicki T, Kirkwood T (2007) The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol. BMC Geriatr 7:14PubMedCentralPubMedCrossRefGoogle Scholar
  13. Collerton J, Davies K, Jagger C, Kingston A, Bond J, Eccles MP, Robinson LA, Martin-Ruiz C, von Zglinicki T, James OF, Kirkwood TB (2009) Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 339:b4904PubMedCentralPubMedCrossRefGoogle Scholar
  14. Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood TB (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mech Ageing Dev 133:456–466PubMedCrossRefGoogle Scholar
  15. Costello JF, Plass C (2001) Methylation matters. J Med Genet 38:285–303PubMedCentralPubMedCrossRefGoogle Scholar
  16. Davies K, Collerton JC, Jagger C, Bond J, Barker SA, Edwards J, Hughes J, Hunt JM, Robinson L (2010) Engaging the oldest old in research: lessons from the Newcastle 85+ study. BMC Geriatr 10:64PubMedCentralPubMedCrossRefGoogle Scholar
  17. DeVos L, Chanson A, Liu Z, Ciappio ED, Parnell LD, Mason JB, Tucker KL, Crott JW (2008) Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am J Clin Nutr 88:1149–1158PubMedCentralPubMedGoogle Scholar
  18. DiPenta JM, Johnson JG, Murphy RJ (2004) Natural killer cells and exercise training in the elderly: a review. Can J Appl Physiol 29:419–443PubMedCrossRefGoogle Scholar
  19. Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM, Study of Osteoporotic Fractures Research, G (2007) Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol Ser A Biol Sci Med Sci 62:744–751CrossRefGoogle Scholar
  20. Fraga MF, Esteller M (2007) Epigenetics and aging: the targets and the marks. Trends Genet 23:413–418PubMedCrossRefGoogle Scholar
  21. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research, G (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci 56:M146–M156CrossRefGoogle Scholar
  22. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, Miyazaki T, Ogura C, Okazaki Y, Jinno Y (2004) Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 68:196–204PubMedCrossRefGoogle Scholar
  23. Gautrey HE, Otterdijk, SD, Cordel, HJ, Newcastle 85+ Study Core Team, Mathers JC, Strathdee G (2014) DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells. FASEB J (in press)Google Scholar
  24. Gopalakrishnan S, Van Emburgh BO, Robertson KD (2008) DNA methylation in development and human disease. Mutat Res 647:30–38PubMedCentralPubMedCrossRefGoogle Scholar
  25. Ho V, Massey TE, King WD (2011) Thymidylate synthase gene polymorphisms and markers of DNA methylation capacity. Mol Genet Metab 102:481–487PubMedCrossRefGoogle Scholar
  26. Huidobro C, Fernandez AF, Fraga MF (2013) The role of genetics in the establishment and maintenance of the epigenome. Cell Mol Life Sci 70:1543–1573PubMedCrossRefGoogle Scholar
  27. Huppert FA, Solomou W, O’Connor S, Morgan K, Sussams P, Brayne C (1998) Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp Gerontol 33:593–600PubMedCrossRefGoogle Scholar
  28. Kulminski A, Yashin A, Arbeev K, Akushevich I, Ukraintseva S, Land K, Manton K (2007) Cumulative index of health disorders as an indicator of aging-associated processes in the elderly: results from analyses of the National Long Term Care Survey. Mech Ageing Dev 128:250–258PubMedCentralPubMedCrossRefGoogle Scholar
  29. Lipsitz LA (2002) Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol Ser A Biol Sci Med Sci 57:B115–B125CrossRefGoogle Scholar
  30. Martin-Ruiz C, Jagger C, Kingston A, Collerton J, Catt M, Davies K, Dunn M, Hilkens C, Keavney B, Pearce SH, den Elzen WP, Talbot D, Wiley L, Bond J, Mathers JC, Eccles MP, Robinson L, James O, Kirkwood TB, von Zglinicki T (2011) Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev 132:496–502PubMedCrossRefGoogle Scholar
  31. Mathers JC, Strathdee G, Relton CL (2010) Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 71:3–39PubMedCrossRefGoogle Scholar
  32. Mitnitski A, Song X, Skoog I, Broe GA, Cox JL, Grunfeld E, Rockwood K (2005) Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 53:2184–2189PubMedCrossRefGoogle Scholar
  33. Mitnitski A, Song X, Rockwood K (2013) Assessing biological aging: the origin of deficit accumulation. Biogerontology 14:709–717PubMedCentralPubMedCrossRefGoogle Scholar
  34. Molloy DW, Standish TI (1997) A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr 9:87–94 (discussion 143–150)PubMedCrossRefGoogle Scholar
  35. Nunez J, Minana G, Bodi V, Nunez E, Sanchis J, Husser O, Llacer A (2011) Low lymphocyte count and cardiovascular diseases. Curr Med Chem 18:3226–3233PubMedCrossRefGoogle Scholar
  36. Rakyan VK, Down TA, Maslau S, Andrew T, Yang TP, Beyan H, Whittaker P, McCann OT, Finer S, Valdes AM, Leslie RD, Deloukas P, Spector TD (2010) Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20:434–439PubMedCentralPubMedCrossRefGoogle Scholar
  37. Rattan SI (2013) Healthy ageing, but what is health? Biogerontology 14:673–677PubMedCrossRefGoogle Scholar
  38. Rockwood K, Song X, Mitnitski A (2011) Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey. Can Med Assoc J 183:487–494CrossRefGoogle Scholar
  39. Romero-Ortuno R, O’Shea D, Kenny RA (2011) The SHARE frailty instrument for primary care predicts incident disability in a European population-based sample. Qual Prim Care 19:301–309PubMedGoogle Scholar
  40. Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J (2009) Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol Ser A Biol Sci Med Sci 64:675–681CrossRefGoogle Scholar
  41. Song X, Mitnitski A, Rockwood K (2010) Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 58:681–687PubMedCrossRefGoogle Scholar
  42. Struck AW, Thompson ML, Wong LS, Micklefield J (2012) S-adenosyl-methionine-dependent methyltransferases: highly versatile enzymes in biocatalysis, biosynthesis and other biotechnological applications. Chembiochem 13:2642–2655Google Scholar
  43. Tapp HS, Commane DM, Bradburn DM, Arasaradnam R, Mathers JC, Johnson IT, Belshaw NJ (2013) Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa. Aging Cell 12:148–155PubMedCentralPubMedCrossRefGoogle Scholar
  44. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54:991–1001PubMedCrossRefGoogle Scholar
  45. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39:457–466PubMedCrossRefGoogle Scholar
  46. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33:6823–6836PubMedCentralPubMedCrossRefGoogle Scholar
  47. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM (2010) Vitamin D deficiency and frailty in older Americans. J Intern Med 268:171–180PubMedCentralPubMedCrossRefGoogle Scholar
  48. Xue QL (2011) The frailty syndrome: definition and natural history. Clin Geriatr Med 27:1–15PubMedCentralPubMedCrossRefGoogle Scholar
  49. Xue QL, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP (2008) Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging Study II. J Gerontol Ser A Biol Sci Med Sci 63:984–990CrossRefGoogle Scholar
  50. Zhang D, Cheng L, Badner JA, Chen C, Chen Q, Luo W, Craig DW, Redman M, Gershon ES, Liu C (2010) Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet 86:411–419PubMedCentralPubMedCrossRefGoogle Scholar
  51. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, Yang AS, Vokonas P, Lissowska J, Fustinoni S, Pesatori AC, Bonzini M, Apostoli P, Costa G, Bertazzi PA, Chow WH, Schwartz J, Baccarelli A (2012) Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 41:126–139PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Joanna Collerton
    • 1
  • Hannah E. Gautrey
    • 2
  • Sanne D. van Otterdijk
    • 2
  • Karen Davies
    • 1
  • Carmen Martin-Ruiz
    • 1
  • Thomas von Zglinicki
    • 1
  • Thomas B. L. Kirkwood
    • 1
  • Carol Jagger
    • 1
  • John C. Mathers
    • 3
  • Gordon Strathdee
    • 2
    Email author
  1. 1.Institute for Ageing and HealthNewcastle UniversityNewcastle upon TyneUK
  2. 2.Northern Institute for Cancer ResearchNewcastle UniversityNewcastle upon TyneUK
  3. 3.Human Nutrition Research Centre, Institute for Ageing and HealthNewcastle UniversityNewcastle upon TyneUK

Personalised recommendations